Search results
Mar 21, 2024 · FIND accelerates equitable access to reliable diagnosis around the world. We are working to close critical testing gaps that leave people at risk from preventable and treatable illnesses, enable effective disease surveillance, and build sustainable, resilient health systems.
- Departments
Departments - FIND | Diagnosis for all
- Working at Find
Working at Find - FIND | Diagnosis for all
- Calls for Partners
Global commercialization of a core antigen rapid diagnostic...
- About Us
About us. We are a global non-profit connecting countries...
- Antimicrobial Resistance
AMR is one of the top ten threats to global public health....
- Contact
Contact - FIND | Diagnosis for all
- New Delhi, India
Our India office opened in 2007, in New Delhi. Established...
- Covid-19
Covid-19 - FIND | Diagnosis for all
- Find Policies
Find Policies - FIND | Diagnosis for all
- Strategy
Our strategy seeks to harness the momentum around testing...
- Departments
We are a global non-profit connecting countries and communities, funders, decisionmakers, healthcare providers and developers to spur diagnostic innovation and make testing an integral part of sustainable, resilient health systems.
FIND is a global health non-profit based in Geneva, Switzerland. FIND functions as a product development partnership, engaging in active collaboration with over 150 partners to facilitate the development, evaluation, and implementation of diagnostic tests for poverty-related diseases. The organisation's Geneva headquarters are in Campus Biotech.
- Bill Rodriguez
- Geneva
- 2003
People also ask
What is the global diagnostics Alliance?
Who is a member of the global diagnostics Alliance?
Which R&D blueprint pathogens have significant diagnostic gaps?
Our strategy. Accelerating global efforts towards universal health coverage and global health security. Our strategy seeks to harness the momentum around testing for COVID-19, exploiting emerging digital innovations, and building on our organization’s 20-year experience as a product development partnership focused on diagnosis of tuberculosis ...
About us. FIND seeks to ensure equitable access to reliable diagnosis around the world. We connect countries and communities, funders, decision-makers, healthcare providers and developers to...
Sep 6, 2022 · GENEVA, SWITZERLAND – 6 September 2022 – FIND, the global alliance for diagnostics, and Unitaid announced today that a new US$15.9 million grant has been signed to accelerate the introduction of new TB diagnostics that can address barriers to access and improve case detection at primary healthcare and community levels.
Diagnostic tests are critical for both pandemic preparedness and outbreak response. COVID-19 led to more than 3 million deaths cost between US$8.1 and US$15.8 trillion globally. Better preparedness against future threats is essential. Aurélia Vessière. Deputy Director, Pandemic Threats.
